Table 2. Laboratory assessment.
Laboratory assessment | Reference ranges | Total patients after atrial switch operation | Mustard | Senning |
---|---|---|---|---|
Aspartate aminotransferase (U/L) | 10–35 | 33 [14–61] | 30 [14–19] | 33 [15–61] |
Alanin aminotransferase (U/L) | 10–35 | 41 [13–148] | 37 [14–49] | 41 [13–148] |
Alcalic phosphatase (U/L) | 55–105 | 70 [49–193] | 70 [49–193] | 70 [49–95] |
Gamma glutamyl transferase (U/L) | 5–40 | 42 [16–336] | 40 [16–336] | 43 [23–161] |
Cholinesterase (kU/L) | 5.5–13 | 7.6 [6.0–11.2] | 7.1 [6.0–11.0] | 8.0 [6.2–11.2] |
Cholesterol (mg/dL) | 130–200 | 174 [131–237] | 178 [150–206] | 162 [131–237] |
Total bilirubin (mg/dL) | ≤1.2 | 0.8 [0.3–2.4] | 0.6 [0.3–2.4] | 1.0 [0.4–2.0] |
INR† | NA | 1.0 [0.9–1.3] | 1.0 [0.9–1.1] | 1.1 [1.0–1.3] |
aPTT (s)† | 24–40 | 33 [29–43] | 30 [29–43] | 33 [30–43] |
Fibrinogen (mg/dL) | 180–350 | 302 [183–432] | 307 [236–432] | 300 [183–419] |
Albumin (g/L) | 35–52 | 46 [42–54] | 46 [43–47] | 46 [42–54] |
Hemoglobin (g/dL) | 11–14 | 16.0 [12.1–18.1] | 15.3 [12.1–18.1] | 16.0 [14.1–17.5] |
Hematocrit (L/L) | 0.36–0.43 | 0.46 [0.35–0.53] | 0.45 [0.35–0.53] | [0.46 [0.42–0.51] |
Platelets (count/nL) | 140–400 | 221 [121–319] | 224 [121–305] | 218 [142–319] |
NTproBNP (ng/L)‡ | ≤400 | 244 [36–535] | 502 [274–535]* | 153 [36–507]* |
All values are presented as median [range]. †, without three patients who were treated with warfarin; ‡, NTproBNP levels were available only in n=13 patients in total, thereof n=4 in the Mustard and n=9 in the Senning group; *, statistical significance with P<0.05. NA, not available; INR, international normalized ratio; aPTT, activated partial thromboplastin time.